"Concerns persist regarding tactics that some authors continue to use (knowingly or unknowingly) in order to get their trial reports into the publication pipeline. We are disappointed that these highly questionable practices continue. In some cases, we are dealing with quite blatant inaccuracies." - Jane Noyes, Journal of Advanced Nursing

https://onlinelibrary.wiley.com/doi/10.1111/jan.15620

HT #Transparimed on 🐦

#ClinicalTrials #AllTrials #ReportingGuidelines

"We are disappointed that these highly questionable practices continue. In some cases, we are dealing with quite blatant inaccuracies. In the most serious cases, we have written to the author's institution to share our concerns…The longer-term goal needs to be raising author awareness about research #misconduct and #fraud and to ensure better compliance with journal eligibility criteria and the requirements of the #AllTrials Initiative."
https://onlinelibrary.wiley.com/doi/10.1111/jan.15620

#ClinicalTrials #Data #OpenData

We wrote a post with a more outreachy style:
https://chemistrycommunity.nature.com/posts/data-driven-design-of-molecular-nanomagnets

Obligatory notes:
cc @wim_v12e #JevonsParadox #FrugalComputing
cc @jessRmorley #AllTrials #DataScience

Medizinische Forschung, deren Ergebnisse nicht zugänglich sind, nützt niemandem.

Ich frage Jens Spahn und EU-Kommission, wer für nicht verzeichnete klinische Studienergebnisse verantwortlich ist, berichtet @[email protected]:

https://www.transparimed.org/single-post/2020/01/05/BfArM-PEI-klinische-versuche-transparenz #AllTrials #Piraten